Premium
Nasal T‐cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases
Author(s) -
GORP J.VAN,
BRUIN P.C.DE,
SIEGO D.M.D.S.,
HEERDE P. VAN,
OSSENKOPPELE G.J.,
RADEMAKERS L.H.P.M.,
MEIJER C.J.L.M.,
TWEEL J.G.VAN DEN
Publication year - 1995
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.1995.tb00022.x
Subject(s) - immunophenotyping , lymphoma , cytotoxic t cell , pathology , chemotherapy , radiation therapy , medicine , t cell lymphoma , epstein–barr virus , virus , biology , immunology , antigen , biochemistry , in vitro
Thirteen cases of nasal lymphomas with T‐cell or natural killer (NK)‐cell phenotype were studied, with attention to clinical presentation and follow‐up, the presence of Epstein‐Barr virus (EBV) using in situ hybridization (EBER), the immunophenotype, and the presence of cytotoxic granules. All but two patients presented with stage I disease. In three cases local progression resulted in involvement of the central nervous system. When dissemination occurred, this was predominantly to extranodal localizations, in two cases to the skin. Response to therapy was highly variable, but patients treated with radiotherapy with or without additional chemotherapy had a better prognosis than patients treated with initial chemotherapy alone. All lymphomas were associated with EBV, and most cases howed cytotoxic features, ten of which were CD56 positive. In eight cases a T‐cell origin was proven, but in five ases a possible NK‐cell origin could not be excluded, No clinical differences were seen between true T‐cell lymphomas and possible NK‐cell neoplasms. Nasal T‐cell lymphomas should be considered as a distinct clinicopathological entity, strongly associated with EBV, and with cytotoxic features in most cases. No prognostic parameters were detected to predict dissemination and response to therapy.